Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)

Not Applicable

Completed

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

Interventions: Other: COPD Education Only
Other: COPD plus CAPTURE education and patient-level information

First Posted Date: 2018-07-11

Last Posted Date: 2023-10-23

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 2008

Registration Number: NCT03583099

Locations: 🇺🇸
LANet, Los Angeles, California, United States
🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

and more 6 locations

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)

Completed

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

Interventions: Other: CAPTURE Tool

First Posted Date: 2018-07-10

Last Posted Date: 2023-06-07

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 4679

Registration Number: NCT03581227

Locations: 🇺🇸
High Plains Research Network, Aurora, Colorado, United States
🇺🇸
LANet, Los Angeles, California, United States
🇺🇸
Duke University, Durham, North Carolina, United States

and more 5 locations

Pseudo-Simultaneous Imaging of Tumor Hypoxia and Proliferation in HNC Patients Using PET/CT

Early Phase 1

Withdrawn

Conditions: Head and Neck Cancer

Interventions: Diagnostic Test: PET/CT Imaging

First Posted Date: 2018-06-07

Last Posted Date: 2021-12-29

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT03548727

Locations: 🇺🇸
Citigroup Biomedical Imaging Center, New York, New York, United States

177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC

Phase 1

Terminated

Conditions: Prostate Cancer

Interventions: Drug: 177Lu-PSMA-617
Drug: 177Lu-J591
Drug: 68Ga-PSMA-HBED-CC

First Posted Date: 2018-06-04

Last Posted Date: 2021-08-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 6

Registration Number: NCT03545165

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

CC486-CHOP in Patients With Previously Untreated Peripheral T-cell Lymphoma

Phase 2

Completed

Conditions: Previously Untreated Peripheral T-cell Lymphoma

Interventions: Drug: CC-486 Administration
Drug: CHOP Administration

First Posted Date: 2018-05-31

Last Posted Date: 2023-08-22

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 21

Registration Number: NCT03542266

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 1 locations

A Personalized Health Behavior System

Not Applicable

Completed

Conditions: Aging
Social Isolation
Physical Activity

Interventions: Behavioral: Intervention Condition
Behavioral: Control Condition

First Posted Date: 2018-05-25

Last Posted Date: 2022-10-12

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 181

Registration Number: NCT03538158

Locations: 🇺🇸
University of Miami Miller School of Medicine, Miami, Florida, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States

Effect of Food Order on Postprandial Glucose Excursions in Pre-Diabetes

Not Applicable

Completed

Conditions: Pre-Diabetes
Obesity

Interventions: Behavioral: Food Order
Behavioral: Carbohydrate Last
Behavioral: Vegetables first

First Posted Date: 2018-05-24

Last Posted Date: 2018-05-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 15

Registration Number: NCT03536364

Locations: 🇺🇸
Comprehensive Weight Control Center, New York, New York, United States

Impact of Escitalopram on Sperm DNA Fragmentation

Phase 2

Recruiting

Conditions: Sperm DNA Fragmentation
Infertility, Male

Interventions: Other: Placebo
Drug: Escitalopram

First Posted Date: 2018-05-16

Last Posted Date: 2024-03-25

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 70

Registration Number: NCT03527043

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Randomized Trial Comparing EmbryoScope With EmbryoScope+.

Not Applicable

Terminated

Conditions: Infertility

Interventions: Device: EmbryoScope
Device: EmbryoScope+

First Posted Date: 2018-05-11

Last Posted Date: 2019-05-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 18

Registration Number: NCT03522350

Locations: 🇺🇸
Center for Reproductive Medicine, New York, New York, United States

HIPEC After Radical Cystectomy for High Risk Bladder Cancer

Not Applicable

Completed

Conditions: Invasive Bladder Cancer

Interventions: Procedure: HIPEC

First Posted Date: 2018-05-02

Last Posted Date: 2023-08-28

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 7

Registration Number: NCT03514888

Locations: 🇺🇸
Weill Cornell Medicine - New York Presbyterian Hospital, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy